Skip to content

Effects of different cardiac rehabilitation models on the cardiopulmonary function of patients with acute coronary syndrome after percutaneous coronary intervention

Effects of hospital-based and home-based cardiac rehabilitation on the cardiopulmonary function of patients with acute coronary syndrome after percutaneous coronary intervention

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046626
Enrollment
Unknown
Registered
2021-05-23
Start date
2021-05-20
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Interventions

hospital-based group:hospital-based cardiac rehabilitation
home-based group:home-based cardiac rehabilitation

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient was clearly diagnosed as acute coronary syndrome on admission and successfully underwent percutaneous coronary intervention; 2. The condition is stable after PCI treatment, reference standard: no new or recurring chest pain in the past 8 hours; myocardial injury marker levels [creatine kinase (CK)-MB and troponin] no further increase; no significant Signs of decompensation of heart failure (respite breathing accompanied by moist crackles at rest); no new severe arrhythmia or ECG changes in the past 8 hours; 3. Accept the acute phase cardiac rehabilitation intervention in the hospital; 4. No cognitive dysfunction.

Exclusion criteria

Exclusion criteria: 1. Complications such as coronary artery dissection, acute vascular occlusion, and acute heart failure during or after surgery; 2. Accept valve replacement surgery; 3. History of severe arrhythmia or cardiogenic shock; 4. Severe hypertension; 5. History of coronary artery bypass graft; 6. NYHA heart function classification IV; 7. Peripheral vascular disease, renal insufficiency; 8. Combined with malignant tumors, hyperthyroidism, anemia, severe lung diseases, neurological and motor system diseases, etc.

Design outcomes

Primary

MeasureTime frame
Peak oxygen consumption;

Secondary

MeasureTime frame
grip index;6 minutes walking distance;Health Survey Summary;Echocardiogram;Blood Biochemistry;

Countries

China

Contacts

Public ContactGui Peijun

Beijing Friendship Hospital, Captital Medical University

guipeijun@ccmu.edu.cn+86 15810225892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026